Search Results - "Mesens, J"

Transdermal alniditan delivery by skin electroporation by Jadoul, A., Lecouturier, N., Mesens, J., Caers, W., Préat, V.

“…The aim of this study was to evaluate the transdermal permeation of alniditan by electroporation and to compare with iontophoretic delivery. The influence of…”
Get full text

A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats by Vollmer, U, Müller, B W, Peeters, J, Mesens, J, Wilffert, B, Peters, T

“…2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CyD) and 2,6-dimethyl-beta-cyclodextrin (D-beta-CyD) were studied for transdermal penetration enhancement of the…”
Get more information

Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium by Jansen, T, Xhonneux, B, Mesens, J, Borgers, M

“…Beta-cyclodextrins are cyclic molecules with a hydrophilic outer side and a central hydrophobic cavity. Through the inclusion of drug molecules into their…”
Get more information

Hydroxypropyl-beta-cyclodextrin can modulate the activity of spinally administered sufentanil by Meert, T F, Mesens, J, Verheyen, P, Noorduin, H

“…Hydroxypropyl-beta-cyclodextrin increased the effectiveness of sufentanil after epidural and intrathecal administration in rats, both in terms of a longer…”
Get more information

Erbulozole (P.I.N.N.) (R 55 104) encapsulated into cyclodextrins: has it a combined antitumoral and radioprotective potential? by Distelmans, W, Van Ginckel, R, Vanherck, W, Willebrords, R, Wouters, L, De Brabander, M, Mesens, J

“…The clinically applicable formulation of the microtubule inhibitor erbulozole (R 55 104), dissolved into an aqueous hydroxypropyl-beta-cyclodextrin solution…”
Get more information

Transdermal permeation of alniditan by iontophoresis : In vitro optimization and human pharmacokinetic data by JADOUL, A, MESENS, J, CAERS, W, DE BEUKELAAR, F, CRABBE, R, PREAT, V

“…The aim of this paper was to assess the feasibility of electrically enhanced transdermal delivery of alniditan, a novel 5 HT1D agonist for the treatment of…”
Get full text